Can a Nurse-Led support program calm fears after a leukemia diagnosis?
NCT ID NCT07499765
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study looks at whether a formal care support program, led by a specialized nurse, can reduce anxiety in people who have just been told they have acute leukemia. About 110 patients will be split into two groups: one gets the extra support, the other does not. Researchers will measure changes in anxiety using a standard questionnaire.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- care support program with a specialized nurse
- What this could lead to
- If it works, this could show that structured emotional support after a leukemia diagnosis helps lower patient anxiety.
- What could go wrong
- This is a small, early-stage study focused on anxiety, not on treating the leukemia itself. The results may not apply to all patients or hospitals.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
About 110 people
The number the study aims to enrol. It can still change while the study runs.
- Expected to start
-
Mar 2026
An estimate. Start dates often move.
- Expected to finish
-
Apr 2029
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
26 to 80 years
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * informed consent signed * medical confirmation of acute leukemia diagnosis * age equal of superior to 26 years and under 80 years * confirmed diagnosis not yet treated * hospitalization at Centre Henri Becquerel * member or beneficiary of a social security Exclusion Criteria: * -Patient unable to understand the study for any reason or to comply with the trial's requirements * Patient in relapse of acute leukemia * Patient diagnosed with acute myeloid leukemia 3 * History of cancer within the 5 years preceding the year of study enrollment * Alcohol and drug abuse * Inclusion in another therapeutic trial that prevents further enrollment in a trial evaluating quality of life or psychological well-being * Diagnosed psychiatric illness * Patient under guardianship, curatorship, or legal protection
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Acute leukemia are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
Centre Henri Becquerel
RECRUITINGRouen, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Tweaking donor cells may shield older transplant patients from a dangerous complication
- Vaccine aims to train immune system against blood cancers
- Aloe vera mouthwash tested against chemotherapy mouth sores
- Can blood tests predict transplant complications?
- Can a Three-Drug combo shield stem cell transplant patients from a dangerous immune attack?
- Could muscle loss predict blood cancer outcomes?